ESGO 2025 Abstract Submission Overview
Abstracts Submission is Now Open
for an Oral, Poster, Surgical Video Session or LBA Place Holder
Submission Timeline
-
June 2024
ESGO 2025 Abstract Submission Opens for
- Regular Abstracts (Oral, Poster, Video)
- Late-Breaking Place Holder
until
October 28, 2024 (23:59 CET)
-
December 15, 2024
Notification sent to authors about abstract acceptance
-
December 30, 2024
Deadline for registration of presenting authors of accepted abstracts
-
January 15, 2025
Late-breaking Abstract Submission Deadline*
* Only submitters of the preliminary place holder abstract will be able to submit the final updated data and results during the Late-Breaking Abstract submission opening on January 2, 2025.
-
January 23, 2025
Notification sent to authors of accepted late breaking abstracts
-
January 31, 2025
Announcement of accepted abstracts (title, presenting author) and the distribution into sessions on website
Publication Schedule of Accepted Abstracts
-
February 10, 2025 at 12:00 CEST
All regular abstracts accepted for presentation will be published online on website, also in the supplement of the International Journal of Gynecological Oncology and in the congress mobile app.
-
February 20, 2025 at 09:00 CEST
All Late-breaking abstracts accepted for presentation will be published online on website on the first congress day, also in the supplement of the International Journal of Gynecological Oncology and in the congress mobile app.
Embargo policy
Data and information included in accepted abstracts is under embargo until the relevant embargo release date mentioned above.
Important Deadlines
Changes in Accepted Abstracts Timeline
-
January 15, 2025
- Deadline for typos and minor corrections within the abstract
- Deadline for withdrawing the abstract
- Deadline for presenting author change
-
January 31, 2025 for LBA
- Deadline for typos and minor corrections within the abstract
- Deadline for withdrawing the abstract
- Deadline for presenting author change
Please be aware that after these deadlines no changes are possible!
Final Data Submission Dates
-
February 5, 2025
Deadline for submitting final presentation
for abstracts selected for Best oral sessions
-
February 10, 2025
Deadline for submitting
ePosters and amended videos
Key Reasons to Submit Your Abstract
- Showcase your research on a global stage:
Discuss and share your findings with over 2500 international peers from 100+ countries.
- Gain visibility:
All accepted abstracts will be published in an online supplement to the International Journal of Gynecological Cancers (IJGC)*.
- Opportunity for oral presentation:
Authors of outstanding abstracts will have the opportunity to present their work in diverse sessions at the ESGO congress (see below presentation formats)
- Are you a fellow, trainee or under 40?
Special opportunities for young investigators, who have an exceptional research, to present their work at the ESGO Congress.
Oral Presentation Formats
Best Oral / Best LBA Session
In each session, there will be 4 selected abstracts of 10 minutes each and a lecture by invited discussant followed by Q&A.
Mini Oral Session
In each session, there will be 8 selected abstracts of 5 minutes each, followed by 2 min discussion.
Best Three Minute Presentations
A special format of 12 selected presentations of 3 minutes each (1 slide) followed by Q&A.
Young Investigator Session
At this special session, 9 abstracts of 4 minutes each will be selected for oral presentations followed by Q&A.
Video Session
In each session, the chair of the session can present a video which will be followed by 4-5 selected video presentations of 10 minutes each, followed by Q&A.
Interested in exploring ESGO's 2024 Congress Abstracts?
Over 1,200 accepted abstracts (including Late-breaking abstracts) have been published in the online supplement of the International Journal of Gynaecological Cancer*.
* International Journal of Gynecological Cancer (IJGC)
ESGO's official journal IJGC is an international journal, devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract.
Any Questions?
If you have questions regarding abstracts or need assistance, please contact:
Jakub Novak, Abstracts co-ordinator
E-mail: jakub.novak@esgo.org
Lenka Hovorkova, Scientific Programme co-ordinator
E-mail: lenka.hovorkova@esgo.org
Tel: +420 607 990 671